Furthermore, a moderate and highly significant correlation was observed between the biomarker panel and GI symptom severity in a clinical IBS cohort as well as in a general population cohort.
← all excerpts
A novel biomarker panel for irritable bowel syndrome and the application in the general population.
1
—
—